Tag: sorafenib
Adding cryoablation to sorafenib improves the efficacy of renal cell carcinoma...
Cryoablation increases the clinical efficacy of treatment with the oral multi-target antitumour drug sorafenib for advanced renal cell carcinoma (RCC), a new study published...
Establishing the evidence base for SIRT in Interventional Oncology
Multidisciplinary oncology thought leaders discuss the personalisation of SIRT, new and recent evidence for the minimally invasive procedure over sorafenib in advanced HCC, the...
SIRT significantly better tolerated than sorafenib, but does not increase overall...
The 459-patient randomised controlled SARAH study shows that local treatments of advanced or inoperable hepatocellular carcinoma with selective internal radiation therapy (SIRT) did not...
Sorafenib: A good candidate for hepatocellular carcinoma chemoembolization
By Alexandre Laurent, Laurent Bédouet and Laurence Moine
Chemoembolization with sorafenib (Bayer and Onyx Pharmaceuticals) is a promising technique for the treatment of hepatocellular carcinoma...
SARAH study results to be presented as oral abstract at April...
Sirtex has announced that the SARAH (Sorafenib vs. radioembolisation in advanced hepatocellular carcinoma) randomised controlled study results will be presented at the upcoming European...
